Loading...
Loading...

Astonea Labs Ltd., incorporated in 2017, specializes in contract manufacturing of pharmaceutical and cosmetic products for domestic and international companies. Their product range includes antibiotics, anti-cold medicines, antihistamines, and treatments for various health issues.
May 27
May 29
May 30
Jun 2
Jun 2
Jun 3
May 27
May 29
May 30
Jun 2
Jun 2
Jun 3
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 0.70x | Partially Subscribed |
| NII (Non-Institutional Investors/HNI) | 5.60x | Oversubscribed |
| RII (Retail Individual Investors) | 1.69x | Oversubscribed |
| Total Subscription | 1.79x | Oversubscribed |
Last updated: May 29, 2025, 06:21 PM
Detailed breakdown of financial metrics across years
| Financial Metric | 2024 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ₹80.89 Cr | ₹80.89 Cr | ₹64.28 Cr | ₹52.91 Cr |
| Net Worth | ₹11.97 Cr | ₹11.97 Cr | ₹8.16 Cr | ₹7.49 Cr |
| Profit After Tax | ₹3.81 Cr | ₹3.81 Cr | ₹0.67 Cr | ₹0.25 Cr |
| Reserves and Surplus | ₹4.37 Cr | ₹4.37 Cr | ₹4.16 Cr | ₹3.49 Cr |
| Revenue | ₹80.29 Cr | ₹80.29 Cr | ₹67.26 Cr | ₹30.17 Cr |
| Total Borrowing | ₹42.4 Cr | ₹42.4 Cr | ₹35.99 Cr | ₹29.52 Cr |
Competitive advantages and positive aspects
| Face Value | ₹10 per share |
| Fresh Issue | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
| IPO Date | May 27, 2025 to May 29, 2025 |
| Issue Price | ₹135 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Listing Date | June 3, 2025 |
| Lot Size | 1,000 Shares |
| Market Maker Portion | 1,44,000 shares |
| Share Holding Post Issue | 1,05,11,000 shares |
| Share Holding Pre Issue | 77,21,000 shares |
| Total Issue Size | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
| Share Holding Post Issue | 72.30% |
| Share Holding Pre Issue | 98.42% |
| ₹135 per share |
| 544409 |
| INE0TG901011 |
| June 3, 2025 |